Huang H, Lu L, Chen Y, Zeng Y, Xu C. The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis. Nutr J. 2022;21:1–11 BioMed Central. Available from: https://nutritionj.biomedcentral.com/articles/10.1186/s12937-022-00777-x. Cited 2022 May 7.
Zeid W, Ezzeldeen E, Khattab M, Ahmed S, Abdo M. Effect of vitamin D3 (cholecalciferol) supplementation on gastrointestinal symptoms in patients with irritable bowel syndrome attending El-Mahsama Family Practice Center, Ismailia, Egypt: a randomized clinical trial. Al-Azhar Int Med J. 2020;0:0.
Williams CE, Williams EA, Corfe BM. Vitamin D supplementation in people with IBS has no effect on symptom severity and quality of life: results of a randomised controlled trial. Eur J Nutr. 2022;61:299–308. Springer Berlin Heidelberg. https://doi.org/10.1007/s00394-021-02633-w.
Jalili M, Vahedi H, Poustchi H, Hekmatdoost A. Effects of vitamin D supplementation in patients with irritable bowel syndrome: a randomized, double-blind, placebo-controlled clinical trial. Int J Prev Med. 2019;10:16.
Abuelazm M, Muhammad S, Gamal M, Labieb F, Amin MA, Abdelazeem B, et al. The effect of vitamin D supplementation on the severity of symptoms and the quality of life in irritable bowel syndrome patients: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2022;14.
Chong RIH, Yaow CYL, Loh CYL, Teoh SE, Masuda Y, Ng WK, et al. Vitamin D supplementation for irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2022; John Wiley & Sons, Ltd. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/jgh.15852. Cited 2022 Apr 17.
Abuelazm M, Abdelazeem B. Vitamin D supplementation for irritable bowel syndrome: concerns about the meta-analysis. J Gastroenterol Hepatol. 2022;37:1402–3.
Pan A, Hu FB. Question about a recent meta-analysis of low-calorie sweeteners and body weight. Am J Clin Nutr. 2014;100:1604 Oxford Academic. Available from: https://academic.oup.com/ajcn/article/100/6/1604/4576672. Cited 2022 May 8.
Parastouei K, Rostami H. Comment on “Pistachios and cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled clinical trials”. Complement Ther Med. 2021;70:102717 Churchill Livingstone.
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94 Elsevier. Available from: http://www.jclinepi.com/article/S0895435610003306/fulltext. Cited 2022 May 8.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. Cochrane Handb Syst Rev Interv. 2019:1–694.
Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119:126–35 Pergamon.